NFKB1 and Parkinson disease: Research has indicated that butyrate significantly improves intestinal dysfunction and motor deficits in PD animal models by inhibiting the TLR4/MyD88/NF-κB inflammatory pathway, thereby blocking the transmission of inflammatory signals along the gut-brain axis and providing neuroprotective effects.78